Live Chat ×
Skip to main content

Considerations for Tissue Acquisition and Diagnostic Testing in Metastatic Non-Small Cell Lung Cancer


This presentation will discuss the importance of biomarker testing for patients with metastatic non-small cell lung cancer and considerations for sample acquisition to ensure appropriate testing and diagnosis. Dr. Gregg will cover best practices and considerations for adequate tissue collection, explore available biomarker diagnostics tests in NSCLC, and review the importance of testing for the EGFR mutations at disease diagnosis.


Click on the title below to REGISTER for the webinar.